New Key Statistics Module, Z-Score and F-Score
NAS:HBIO Key Ratios
Market Cap $ M | 153.31 |
Enterprise Value $ M | 190.42 |
P/E(ttm) | -- |
PE Ratio without NRI | 100.86 |
Forward PE Ratio | -- |
Price/Book | 2.23 |
Price/Sales | 1.41 |
Price/Free Cash Flow | 13.90 |
Price/Owner Earnings | 34.27 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 106.00 |
EPS (TTM) $ | -0.20 |
Beneish M-Score | -3.31 |
10-y EBITDA Growth Rate % | -1.80 |
5-y EBITDA Growth Rate % | -12.40 |
y-y EBITDA Growth Rate % | -81.80 |
EV-to-EBIT | -39.03 |
EV-to-EBITDA | 110.00 |
PEG | -- |
Shares Outstanding M | 43.43 |
Net Margin (%) | -8.18 |
Operating Margin % | -2.00 |
Pre-tax Margin (%) | -7.72 |
Quick Ratio | 0.94 |
Current Ratio | 1.88 |
ROA % (ttm) | -6.25 |
ROE % (ttm) | -11.93 |
ROIC % (ttm) | -1.73 |
Dividend Yield % | -- |
Altman Z-Score | 2.31 |
HBIO Number of Guru Trades
HBIO Volume of Guru Trades
Gurus Latest Trades with NAS:HBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harvard Bioscience Inc Insider Transactions
No Available Data
News about NAS:HBIO
Total 0- 1